Overview

Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone

Status:
Unknown status

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

Summary

This study investigates the hypothesis that ranibizumab injection given into the eye is a safe, efficacious and helping treatment option applied before surgical intervention of the proliferative diabetic retinal eye disorder.

Phase:

Phase 2

Details

Lead Sponsor:

Attila Vajas

Collaborator:

Semmelweis University

Treatments:

Ranibizumab